These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3321 related articles for article (PubMed ID: 9379138)

  • 1. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR; Jurutka PW; Hsieh JC; Thompson PD; Selznick SH; Haussler CA; Whitfield GK
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unique insertion/substitution in helix H1 of the vitamin D receptor ligand binding domain in a patient with hereditary 1,25-dihydroxyvitamin D-resistant rickets.
    Malloy PJ; Xu R; Cattani A; Reyes mL; Feldman D
    J Bone Miner Res; 2004 Jun; 19(6):1018-24. PubMed ID: 15190891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
    Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
    J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements.
    Kimmel-Jehan C; Darwish HM; Strugnell SA; Jehan F; Wiefling B; DeLuca HF
    J Cell Biochem; 1999 Aug; 74(2):220-8. PubMed ID: 10404392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha,25-dihydroxyvitamin D3 inducible transcription factor and its role in the vitamin D action.
    Nezbedova P; Brtko J
    Endocr Regul; 2004 Mar; 38(1):29-38. PubMed ID: 15147236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M; Freedman LP; Li H; Christakos S
    Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
    Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
    J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
    Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
    J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Receptor mediated genomic action of the 1,25(OH)2D3 hormone: expression of the human vitamin D receptor in E. coli.
    Hsieh JC; Nakajima S; Galligan MA; Jurutka PW; Haussler CA; Whitfield GK; Haussler MR
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):583-94. PubMed ID: 7626514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unique tryptophan residue of the vitamin D receptor is critical for ligand binding and transcriptional activation.
    Solomon C; Macoritto M; Gao XL; White JH; Kremer R
    J Bone Miner Res; 2001 Jan; 16(1):39-45. PubMed ID: 11149488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D receptor interactions with the rat parathyroid hormone gene: synergistic effects between two negative vitamin D response elements.
    Russell J; Ashok S; Koszewski NJ
    J Bone Miner Res; 1999 Nov; 14(11):1828-37. PubMed ID: 10571682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All natural DR3-type vitamin D response elements show a similar functionality in vitro.
    Toell A; Polly P; Carlberg C
    Biochem J; 2000 Dec; 352 Pt 2(Pt 2):301-9. PubMed ID: 11085922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of transcriptional activation and DNA-binding functions in the hinge region of the vitamin D receptor.
    Shaffer PL; McDonnell DP; Gewirth DT
    Biochemistry; 2005 Feb; 44(7):2678-85. PubMed ID: 15709781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel mutation in hereditary vitamin D resistant rickets causing exon skipping.
    Hawa NS; Cockerill FJ; Vadher S; Hewison M; Rut AR; Pike JW; O'Riordan JL; Farrow SM
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):85-92. PubMed ID: 8796143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipopolysaccharide negatively modulates vitamin D action by down-regulating expression of vitamin D-induced VDR in human monocytic THP-1 cells.
    Pramanik R; Asplin JR; Lindeman C; Favus MJ; Bai S; Coe FL
    Cell Immunol; 2004; 232(1-2):137-43. PubMed ID: 15876428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D receptors from patients with resistance to 1,25-dihydroxyvitamin D3: point mutations confer reduced transactivation in response to ligand and impaired interaction with the retinoid X receptor heterodimeric partner.
    Whitfield GK; Selznick SH; Haussler CA; Hsieh JC; Galligan MA; Jurutka PW; Thompson PD; Lee SM; Zerwekh JE; Haussler MR
    Mol Endocrinol; 1996 Dec; 10(12):1617-31. PubMed ID: 8961271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction.
    Eelen G; Verlinden L; Rochel N; Claessens F; De Clercq P; Vandewalle M; Tocchini-Valentini G; Moras D; Bouillon R; Verstuyf A
    Mol Pharmacol; 2005 May; 67(5):1566-73. PubMed ID: 15728261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S; Shevde NK; Pike JW
    J Bone Miner Res; 2005 Feb; 20(2):305-17. PubMed ID: 15647825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 167.